Hemiconvulsion-Hemiplegia-Epilepsy Syndrome

Acquired MONDO:0019485 Pathograph 13 Show in embeddings browser Epilepsy Neurological Disease

A catastrophic sequence that unfolds over hours in a previously well toddler. A febrile illness triggers a prolonged convulsive seizure that is clonic and one-sided; by the time it stops the child is hemiplegic; the affected hemisphere swells acutely and then, over months, shrinks into hemiatrophy; and after a latent interval a drug-resistant focal epilepsy emerges from the damaged side. The three stages give the syndrome its name. What makes it mechanistically arresting is not that a long seizure damages brain, which is expected, but that the damage stops at the midline. Nothing in the proposed mechanisms explains why an entire hemisphere is taken and the other spared, and the authors of the standard review say so outright.

Ask OpenScientist

Ask a research question about Hemiconvulsion-Hemiplegia-Epilepsy Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
9
Pathophys.
5
Phenotypes
2
Gaps
13
Pathograph
2
Genes
4
Medical Actions
3
Differentials
2
References
1
Deep Research
🏷

Classifications

Harrison's Part
NEUROLOGIC
🔗

Mappings

MONDO
MONDO:0019485 idiopathic hemiconvulsion-hemiplegia syndrome
skos:exactMatch MONDO
MONDO:0019485 is the idiopathic form, which the review literature identifies as the commonest reported form and which this entry models as its primary subject.
👪

Inheritance

1
Not inherited; genetic factors as predisposition only HP:0003745
The syndrome is acquired, arising from an event rather than a genotype, and it is not transmitted. Genetics enters only as one of several factors that may let a febrile seizure run long enough to do damage, which puts it alongside a focal epileptogenic lesion rather than in a causal role of its own. There is no recurrence risk to counsel on in the usual sense.
Sporadic
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"predisposing factors facilitating prolonged seizure such as genetic factors or focal epileptogenic lesion"
Places genetic factors as predisposing to the prolonged seizure rather than causing the syndrome, which is why this block records sporadic occurrence with a genetic contribution to susceptibility only.
?

Discussions and Knowledge Gaps

2
Every proposed mechanism for this syndrome, prolonged seizure activity, inflammation, blood-brain barrier failure, is bilateral in principle. Why does the injury take one entire hemisphere and stop at the midline?
KNOWLEDGE GAP OPEN hhe_why_only_one_hemisphere
Attached to
pathophysiology#Unexplained Hemispheric Selectivity pathophysiology#Acute Unilateral Cytotoxic Oedema
This is the defining feature of the syndrome and the one thing no account of it explains. The review that assembles the candidate mechanisms says so directly: the factors it lists cannot explain the elective involvement of an entire hemisphere. The difficulty is structural rather than evidential. Prolonged seizure activity, fever, systemic inflammation, and barrier permeability are all whole-brain phenomena, so none has the geometry to produce a lesion bounded by the midline. Something must supply the lateralization, and the candidates fall into three families. It could originate in the seizure itself, if the discharge stays confined to one hemisphere because interhemispheric propagation is limited in the immature brain, which is where the corpus callosum hypothesis comes from and which would make this a disease of a developmental window rather than of any particular insult. It could be vascular or metabolic, if unilateral hyperperfusion or a unilateral failure of autoregulation determines which side decompensates. Or the child could carry a pre-existing asymmetry, subtle enough to be invisible on imaging, that makes one hemisphere both likelier to sustain the seizure and likelier to be injured by it. That last branch is the one with a named molecular candidate: the same review that raises these hypotheses points specifically at CACNA1A, a neuronal calcium channel gene already tied to hemiplegic migraine, as the genetic factor worth pursuing. It is curated in the genetic section as SUSCEPTIBILITY rather than as a cause, because it has been proposed and discussed but never tested in a cohort with this syndrome, and a channel-level predisposition is only one of several routes to a pre-existing asymmetry. The lesional counterpart of the same branch is concrete rather than hypothetical: three surgical cases turned out to have a focal cortical dysplasia that no scan had shown. These make different predictions and none has been tested head to head. The stake is practical as well as intellectual: if lateralization is set by the seizure's propagation, then interrupting propagation early is protective, whereas if it reflects a pre-existing asymmetry, the die is cast before the child ever seizes.
Proposed experiments
Acute multimodal imaging in prolonged unilateral febrile status
exp_hhe_acute_lateralization_imaging_cohort
Prospectively image children presenting with prolonged lateralized febrile status during the acute episode, combining perfusion imaging, diffusion, and barrier-permeability sequences over both hemispheres, and follow them for the development of hemiatrophy and epilepsy. The unaffected hemisphere is the internal control the retrospective literature never has.
Decision criterion
If the hemispheres differ in perfusion or barrier permeability before oedema is established, the lateralization is haemodynamic or vascular and is potentially modifiable acutely. If the two are indistinguishable until oedema appears, the determinant lies upstream in seizure propagation or in a pre-existing asymmetry.
Callosal maturation in affected children versus matched febrile status controls
exp_hhe_callosal_maturation_comparison
Compare corpus callosum size and diffusion metrics between children who developed the syndrome and age-matched children who had prolonged febrile status without it, using imaging obtained as close to the event as possible.
Decision criterion
A systematic difference in callosal maturation would support the interhemispheric-propagation hypothesis and would predict that the age window of the syndrome tracks callosal development. No difference would effectively close that line and redirect attention to vascular and pre-existing-asymmetry accounts.
Show evidence (3 references)
PMID:22341151 SUPPORT Other
"However, these factors cannot explain the elective involvement of an entire hemisphere."
The explicit statement that the assembled mechanisms fail on the syndrome's defining feature, which makes this a genuine gap rather than a curator's doubt.
PMID:22341151 SUPPORT Other
"We draw new hypothesis that may explain the involvement of one hemisphere such as maturation of brain structure such as corpus callosum or genetic factors (CACNA1A gene) that are specifically discussed."
Names the interhemispheric-maturation and genetic directions that two of the proposed experiments are designed to separate.
PMID:25534340 SUPPORT Other
"The aetiology remains unclear. Several mechanisms may contribute to this condition. To improve the outcome, further studies are needed and early diagnosis is essential."
Independent confirmation from a separate summary that the cause is unresolved and plural rather than settled, which is why this is curated as an open gap rather than a contested one.
Experimental work indicates the immature brain resists seizure-induced cell injury, yet this syndrome destroys a hemisphere precisely in that age group. Is the animal evidence not transferable, or is the human injury produced by something other than the seizure itself?
CONTROVERSY UNDER DISCUSSION hhe_immature_brain_resistance_paradox
Attached to
pathophysiology#Inflammation and Blood-Brain Barrier Breakdown pathophysiology#Acute Unilateral Cytotoxic Oedema
The review states that basic science data suggest the immature brain is relatively resistant to injury from status epilepticus. Taken at face value that is in direct tension with a syndrome whose entire clinical content is catastrophic injury from status epilepticus in children under four. Three readings are available. The first treats it as a translation failure: rodent models of status may not reproduce the human situation, and the resistance seen experimentally may not hold for a seizure of this duration in a febrile child. The second, which the review's own emphasis points toward, is that the seizure alone is not what does the damage; the injury requires the inflammatory context of the febrile illness, and the resistant immature brain becomes vulnerable only when inflammation and barrier breakdown are added. That reading is attractive because it explains why the syndrome follows febrile status specifically rather than status of any cause, and it makes fever a mechanistic participant rather than a trigger. The third is that the resistance is real and the syndrome occurs only in the minority of children in whom some additional factor overrides it, which converts the question into one about predisposition. Distinguishing these matters for whether anti-inflammatory treatment during the acute episode is worth studying, which on the second reading it clearly would be and on the first and third much less so.
Proposed experiments
Inflammatory profiling in prolonged febrile status with and without the syndrome
exp_hhe_inflammatory_markers_in_febrile_status
Measure serum and cerebrospinal fluid inflammatory markers during prolonged febrile status epilepticus in children, and compare those who go on to develop hemiplegia and hemiatrophy with those who recover without sequelae, matched for seizure duration.
Decision criterion
A higher inflammatory burden in those who develop the syndrome, at matched seizure duration, would support inflammation as the necessary co-factor and would make acute immunomodulation a rational thing to trial. Comparable inflammation with outcome tracking seizure duration alone would place the weight back on the seizure and on how fast it is stopped.
Show evidence (3 references)
PMID:22341151 SUPPORT Model Organism
"The basic science data suggest that immature brain is relatively resistant to SE-induced cell injury."
States the experimental finding that stands in tension with the clinical syndrome. Tagged MODEL_ORGANISM because the resistance is a basic-science result rather than a human observation, which is itself the first interpretation this discussion weighs.
PMID:22341151 SUPPORT Other
"prolonged febrile seizure in which inflammation may worsen the level of cell injury; 2. inflammation and prolonged ictal activity that act on blood-brain-barrier permeability"
States the inflammatory co-factor reading, the second and most actionable of the three interpretations weighed here.
PMID:22341151 SUPPORT Other
"predisposing factors facilitating prolonged seizure such as genetic factors or focal epileptogenic lesion"
Supports the predisposition reading. Marked PARTIAL because these factors are offered as facilitating the prolonged seizure rather than overriding a resistance to injury, so they bear on the third interpretation only indirectly.
⚙

Pathophysiology

9
Predisposing Factors Facilitating Prolonged Seizure
An upstream node covering what makes a particular child's febrile seizure run on rather than stop. It is also where the boundary between idiopathic and symptomatic cases sits. Two kinds of predisposition are recognized: a focal epileptogenic lesion, which in some cases is a mild cortical malformation only found after surgery, and genetic factors, for which CACNA1A is the one gene the primary literature names in connection with this syndrome. This node is deliberately upstream of, and not identical with, the status epilepticus itself; it is why some children with prolonged febrile seizures develop the syndrome and most do not. It is not a necessary node, since the syndrome occurs in children with no identified predisposition at all.
Downstream
Prolonged Unilateral Febrile Status Epilepticus
Show evidence (2 references)
PMID:22341151 SUPPORT Other
"predisposing factors facilitating prolonged seizure such as genetic factors or focal epileptogenic lesion"
Names both branches of predisposition explicitly, and frames them as facilitating the prolongation of the seizure rather than as causes of the syndrome, which is exactly the position this node occupies.
PMID:31824410 SUPPORT Human Clinical
"The epileptogenic mild cortical malformations may be the cause of HHES."
The lesional branch made concrete: in three surgical cases the predisposing lesion was a focal cortical dysplasia identified only on pathology, which is why an initially normal scan does not exclude a structural predisposition.
Prolonged Unilateral Febrile Status Epilepticus
The initiating event, and it is an event rather than a state: a convulsive seizure during a febrile illness in a child under about four, clonic and predominantly one-sided, which does not stop. Everything that follows is downstream of how long it ran. This is also why the syndrome is in principle preventable in a way most epilepsies are not, since the damage accrues during a window in which someone could be terminating the seizure.
Downstream
Inflammation and Blood-Brain Barrier Breakdown
Unexplained Hemispheric Selectivity
Show evidence (2 references)
PMID:22341151 SUPPORT Other
"Hemiconvulsion-Hemiplegia (HH) syndrome is an uncommon consequence of prolonged focal febrile convulsive seizures in infancy and early childhood."
Names the initiating event and its age window, which is what this node models.
PMID:22341151 SUPPORT Other
"It is characterized by the occurrence of prolonged clonic seizures with unilateral predominance occurring in a child and followed by the development of hemiplegia."
Establishes the unilateral predominance of the seizure itself, the first appearance of the lateralization this entry cannot explain.
Inflammation and Blood-Brain Barrier Breakdown
Two processes are proposed to convert a long seizure into tissue injury, and they reinforce each other. Fever and the underlying illness supply an inflammatory context thought to worsen the cell injury a seizure inflicts, and inflammation together with sustained ictal activity is proposed to compromise the blood-brain barrier. A leaking barrier in a seizing hemisphere is a plausible route from electrical activity to the oedema seen on imaging. Both remain proposals rather than demonstrations here.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Acute Unilateral Cytotoxic Oedema
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"prolonged febrile seizure in which inflammation may worsen the level of cell injury; 2. inflammation and prolonged ictal activity that act on blood-brain-barrier permeability"
States both proposed mechanisms this node models, as contributory factors rather than established steps.
Unexplained Hemispheric Selectivity
The node this entry cannot fill, kept explicit rather than hidden. Whatever converts a prolonged seizure into injury does so on one side of the brain and stops at the midline, and the review that assembles the candidate mechanisms concludes that none of them accounts for this. Suggested directions include the maturational state of interhemispheric connections, the corpus callosum in particular, and genetic factors, but these are offered as hypotheses to test rather than answers. Any model of this syndrome that does not explain the midline is incomplete, and this one does not.
cerebral hemisphere UBERON:0001869 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral hemisphere (UBERON:0001869). UBERON:0001869 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Acute Unilateral Cytotoxic Oedema
Show evidence (2 references)
PMID:22341151 SUPPORT Other
"However, these factors cannot explain the elective involvement of an entire hemisphere."
The authors' own statement that the assembled mechanisms fail to account for the lateralization, which is what this node encodes.
PMID:22341151 SUPPORT Other
"We draw new hypothesis that may explain the involvement of one hemisphere such as maturation of brain structure such as corpus callosum or genetic factors (CACNA1A gene) that are specifically discussed."
Records the proposed directions. Marked PARTIAL because the source presents them explicitly as new hypotheses rather than findings.
Acute Unilateral Cytotoxic Oedema
During and immediately after the status epilepticus, imaging shows the seizing hemisphere swollen with cytotoxic oedema, meaning water has moved into cells that are failing rather than into the interstitium. This is the acute radiological signature and the point at which the diagnosis can be made rather than inferred in retrospect, which matters because it is also the only point at which intervention could plausibly alter the outcome.
cerebral hemisphere UBERON:0001869 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral hemisphere (UBERON:0001869). UBERON:0001869 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Hemiplegia
Progressive Cerebral Hemiatrophy
Show evidence (2 references)
PMID:22341151 SUPPORT Other
"Neuroradiological studies showed unilateral edematous swelling of the epileptic hemisphere at the time of initial status epilepticus (SE)."
Documents the acute swelling and its timing relative to the status epilepticus.
PMID:25534340 SUPPORT Other
"Neuroimaging show unilateral cytotoxic oedema at the initial convulsive state, followed by severe chronic atrophy of the affected hemisphere."
Independently confirms the cytotoxic character of the oedema and its progression to atrophy.
Hemiplegia
Weakness of the side opposite the affected hemisphere, present when the seizure stops rather than developing later, which distinguishes it from a post-ictal Todd paresis that resolves. Its degree varies and it is the second element of the syndrome's name.
Show evidence (1 reference)
PMID:25534340 SUPPORT Other
"Various degrees of hemiplegia and within a variable interval, subsequent epilepsia follows."
Documents the variable severity of the hemiplegia and its position before the epilepsy.
Progressive Cerebral Hemiatrophy
Over the months after the acute event the swollen hemisphere shrinks, ending in severe chronic atrophy of that side alone. The swelling and the atrophy are the same process seen at two timepoints, which is why serial imaging is more informative than any single scan, and why a scan obtained late shows a picture that could be mistaken for a congenital malformation.
cerebral hemisphere UBERON:0001869 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral hemisphere (UBERON:0001869). UBERON:0001869 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Epileptogenic Reorganization of the Damaged Hemisphere
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"This acute phase is followed by characteristic cerebral hemiatrophy with subsequent appearance of epilepsy, so called Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome."
States the progression from acute phase to hemiatrophy to epilepsy, the sequence that defines the full syndrome.
Epileptogenic Reorganization of the Damaged Hemisphere
Between the hemiatrophy and the epilepsy there is a latent interval, the classic signature of epileptogenesis rather than of ongoing seizures: the damaged tissue reorganizes into a network that generates seizures, and that takes time. The interval is variable, which is part of why the eventual epilepsy can seem to arrive out of nowhere in a child whose acute illness was months or years earlier.
Downstream
Drug-Resistant Focal Epilepsy from the Affected Hemisphere
Show evidence (1 reference)
PMID:25534340 SUPPORT Other
"Various degrees of hemiplegia and within a variable interval, subsequent epilepsia follows."
Documents the latent and variable interval before the epilepsy appears, which makes this a reorganization step rather than a direct continuation.
Drug-Resistant Focal Epilepsy from the Affected Hemisphere
The third element of the name and the reason this is a lifelong diagnosis rather than an acute illness. Seizures arise from the atrophic hemisphere and are typically refractory to medication, which is what brings these children to epilepsy surgery: the damaged side is already largely non-functional and the healthy side has had years to take over, so disconnection has an unusually favourable ratio of benefit to further loss.
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"This acute phase is followed by characteristic cerebral hemiatrophy with subsequent appearance of epilepsy, so called Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome."
Establishes that the epilepsy is the defining third stage rather than an incidental comorbidity.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Hemiconvulsion-Hemiplegia-Epilepsy Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

5
Musculoskeletal 1
Spasticity HP:0001257 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Spasticity (HP:0001257). HP:0001257 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:29414550 SUPPORT Human Clinical
"Hemiplegia or spastic hemiparesis of the ipsilateral side to the convulsion was present in all patients."
Names the spastic character of the residual weakness in the largest reported series.
Nervous System 3
Hemiparesis VERY_FREQUENT HP:0001269 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hemiparesis (HP:0001269). HP:0001269 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:22341151 SUPPORT Other
"It is characterized by the occurrence of prolonged clonic seizures with unilateral predominance occurring in a child and followed by the development of hemiplegia."
Documents the hemiplegia and its position immediately after the seizure.
PMID:29414550 SUPPORT Human Clinical
"Hemiplegia or spastic hemiparesis of the ipsilateral side to the convulsion was present in all patients."
Present in all 35 patients of the largest reported series, which is what supports the very frequent band. The source pairs hemiplegia and spastic hemiparesis as alternative severities of one deficit, which is why the broader Hemiparesis term is retained here while the pathophysiology node is named Hemiplegia.
Focal-onset seizure HP:0007359 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal-onset seizure (HP:0007359). HP:0007359 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"This acute phase is followed by characteristic cerebral hemiatrophy with subsequent appearance of epilepsy, so called Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome."
Establishes the epilepsy that follows the hemiatrophy.
Cerebral hemiatrophy Cerebral atrophy HP:0002059 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebral atrophy (HP:0002059), qualified as course progressive. HP:0002059 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (1 reference)
PMID:25534340 SUPPORT Other
"Neuroimaging show unilateral cytotoxic oedema at the initial convulsive state, followed by severe chronic atrophy of the affected hemisphere."
Documents the unilateral atrophy and its severity.
Other 1
Febrile status epilepticus HP:0002133 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Status epilepticus (HP:0002133). HP:0002133 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25534340 SUPPORT Other
"Hemiconvulsion-hemiplegia-epilepsy syndrome is a rare consequence of a status epilepticus in the course of a febrile illness in children under the age of four years."
Names the presenting event, its febrile context, and the age window.
🧬

Genetic Associations

2
CACNA1A
Gene: CACNA1A hgnc:1388 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is CACNA1A (hgnc:1388). hgnc:1388 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: SUSCEPTIBILITY
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"We draw new hypothesis that may explain the involvement of one hemisphere such as maturation of brain structure such as corpus callosum or genetic factors (CACNA1A gene) that are specifically discussed."
The only source-supported naming of a specific gene for this syndrome. Marked PARTIAL because the authors present it explicitly as a new hypothesis they go on to discuss, not as a demonstrated association.
SCN1A
Gene: SCN1A hgnc:10585 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is SCN1A (hgnc:10585). hgnc:10585 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: SUSCEPTIBILITY
Show evidence (2 references)
PMID:23916143 SUPPORT Human Clinical
"Our study suggests that SCN1A genetic mutation is only a rare predisposing cause of HHE syndrome."
The authors' own conclusion, which is precisely the SUSCEPTIBILITY rather than causative relationship curated here.
PMID:23916143 REFUTE Human Clinical
"Direct sequencing of all coding exons and flanking intronic sequences of the SCN1A gene was performed, but we failed to identify additional mutations in 10 patients."
Marked REFUTE against the proposition that SCN1A explains this syndrome. Ten of eleven patients had no mutation on full coding sequencing, which is the direct negative evidence.
💊

Medical Actions

4
Epilepsy surgery, functional hemispherotomy
Action: Surgical ProcedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Surgical Procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. NCIT:C15329
For the drug-resistant epilepsy that follows, disconnection of the damaged hemisphere. The rationale is unusually clean for epilepsy surgery: the seizures arise from a hemisphere that is already destroyed and already producing a hemiplegia, so the functional cost of disconnecting it has largely been paid by the disease. This is the one intervention that addresses the chronic epilepsy at its source rather than suppressing it, and in the reported surgical cases it was reached only after antiseizure drugs failed.
Mechanism Target:
INHIBITS Drug-Resistant Focal Epilepsy from the Affected Hemisphere
Show evidence (1 reference)
PMID:31824410 SUPPORT Human Clinical
"Their seizures were intractable with antiepileptic drugs and required hemispherotomy."
Establishes both that the epilepsy is drug-resistant and that hemispherotomy is the intervention it is escalated to.
Aggressive termination of the status epilepticus
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
The one intervention with a mechanistic claim on the outcome, because the injury accrues while the seizure runs. Everything else in this entry treats consequences. The corollary is uncomfortable and worth stating: by the time the syndrome is recognizable as itself, the treatable window has usually closed, which is why the literature stresses early diagnosis rather than novel therapy.
Mechanism Target:
INHIBITS Prolonged Unilateral Febrile Status Epilepticus
Show evidence (2 references)
PMID:25534340 SUPPORT Other
"To improve the outcome, further studies are needed and early diagnosis is essential."
Supports the emphasis on acting early. Marked PARTIAL because it calls for early diagnosis and further study rather than demonstrating that any particular acute treatment changes the outcome, which is the honest state of the evidence.
PMID:29414550 SUPPORT Human Clinical
"On the one hand, authors highlight the need for improving emergency care of status epilepticus."
A recommendation about status epilepticus management specifically, rather than about the syndrome in general, which is what this treatment record asserts.
Prophylaxis of febrile seizures
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Upstream of everything else. Because the syndrome is the consequence of a prolonged febrile seizure, preventing or shortening febrile seizures prevents the syndrome outright, and in settings where emergency care of status epilepticus is hard to deliver reliably this is argued to be the more realistic lever of the two. That is a statement about health systems as much as about biology, and the source makes it in exactly those terms.
Mechanism Target:
INHIBITS Prolonged Unilateral Febrile Status Epilepticus
Show evidence (1 reference)
PMID:29414550 SUPPORT Human Clinical
"On the other hand, in our context, the prophylaxis of febrile seizures seems to be the corner stone of the prevention of HHE Syndrome."
Names febrile-seizure prophylaxis as the cornerstone of prevention, and scopes the claim to the authors' own setting, which is why the description keeps that qualification.
Antiseizure medication for the established epilepsy
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Medication is used for the late focal epilepsy and frequently fails, which is what brings these children to surgical assessment. Its role is symptom control rather than modification of the underlying damage, which is fixed by the time it is prescribed.
Mechanism Target:
INHIBITS Drug-Resistant Focal Epilepsy from the Affected Hemisphere
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"understanding of the underlying mechanisms of HHE are needed to improve the outcome of this condition"
Supports the position that outcomes are currently unsatisfactory and depend on mechanistic understanding not yet available. Marked PARTIAL because it speaks to the state of the field rather than to the efficacy of any drug.
🔬

Diagnosis

2
Brain MRI, acute and serial
Imaging is what makes the diagnosis, and the timing changes what it shows. Acutely the affected hemisphere is swollen with cytotoxic oedema; months later the same hemisphere is atrophic. A single late scan can therefore be misread as a congenital or long-standing abnormality, which is an argument for imaging during the acute illness rather than only afterwards.
Magnetic Resonance Imaging NCIT:C16809 NCI Thesaurus (NCIT)
Results: Unilateral hemispheric swelling with cytotoxic oedema acutely; severe unilateral hemiatrophy on later imaging.
Show evidence (1 reference)
PMID:25534340 SUPPORT Other
"Neuroimaging show unilateral cytotoxic oedema at the initial convulsive state, followed by severe chronic atrophy of the affected hemisphere."
States both imaging appearances and their timing, which is the content of the results field.
Electroencephalography
Electroencephalography documents the lateralized ictal activity during the acute episode and later characterizes the focal epilepsy arising from the damaged hemisphere, which is the information a surgical assessment needs.
Electroencephalography NCIT:C38054 NCI Thesaurus (NCIT)
Results: Lateralized ictal activity acutely; later, focal epileptiform abnormality over the atrophic hemisphere.
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"Neuroradiological studies showed unilateral edematous swelling of the epileptic hemisphere at the time of initial status epilepticus (SE)."
Establishes that the hemisphere involved is the epileptic one, which is the lateralization electroencephalography demonstrates. Marked PARTIAL because the quoted sentence reports imaging rather than electrographic findings.
📈

Progression

2
Acute hemiconvulsive status with hemiplegia and hemispheric swelling
Age: Under four years
The seizure, the hemiplegia, and the unilateral oedema all belong to the same acute episode, over hours to days. This is the only phase in which the process is plausibly modifiable, which is why early recognition is emphasized in every account of the syndrome.
Show evidence (1 reference)
PMID:25534340 SUPPORT Other
"To improve the outcome, further studies are needed and early diagnosis is essential."
States the emphasis on early diagnosis that this phase turns on.
Hemiatrophy and a latent interval, then epilepsy
Age: Months to years after the acute event
The swollen hemisphere becomes atrophic, and after a variable latent interval a drug-resistant focal epilepsy emerges from it. The interval makes the causal link easy to miss when a child presents years later with seizures and an atrophic hemisphere.
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"This acute phase is followed by characteristic cerebral hemiatrophy with subsequent appearance of epilepsy, so called Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome."
States the sequence of phases this record describes.
📊

Prevalence

1
Children with prolonged febrile seizures
Unknown Ultra Rare
No population-based estimate exists. Both the review literature and the clinical summaries describe the syndrome as uncommon or rare among children who have prolonged febrile seizures, which is a qualitative statement about an already-selected denominator rather than a population rate.
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"Hemiconvulsion-Hemiplegia (HH) syndrome is an uncommon consequence of prolonged focal febrile convulsive seizures in infancy and early childhood."
Supports the rarity band against a denominator of children with prolonged febrile seizures. Marked PARTIAL because it is a descriptor rather than a measurement.
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Hemiconvulsion-Hemiplegia-Epilepsy Syndrome:

Rasmussen Encephalitis MONDO:0016019
Overlapping Features The other childhood syndrome that destroys one hemisphere and leaves a drug-resistant epilepsy, and the closest mimic on a late scan. The distinction is tempo: here the damage is done in a single acute episode and then stops, whereas Rasmussen is a progressive inflammatory process that keeps consuming the hemisphere over years.
Distinguishing Features
  • Damage is inflicted in one acute episode rather than accruing progressively over years.
  • Onset is a febrile status epilepticus, not an insidious increase in seizure frequency.
  • Hemiplegia appears at the outset rather than developing as the hemisphere is progressively lost.
  • No histological evidence of ongoing T-cell-mediated encephalitis.
Show evidence (1 reference)
PMID:22341151 SUPPORT Other
"This acute phase is followed by characteristic cerebral hemiatrophy with subsequent appearance of epilepsy, so called Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome."
Establishes the monophasic acute-then-atrophy course that distinguishes this syndrome from a progressive encephalitis producing the same endpoint.
Dravet Syndrome MONDO:0100135
Overlapping Features Arguably the most consequential differential, because the two syndromes share the thing that defines this one: prolonged, often hemiclonic, fever-provoked seizures in the first years of life. The overlap is close enough that it motivated screening this syndrome for SCN1A in the first place, and close enough that a child can satisfy both descriptions. The separation matters because Dravet is a monogenic channelopathy with its own trajectory and its own contraindicated drugs, whereas this syndrome is an acquired hemispheric injury.
Distinguishing Features
  • Seizures in Dravet recur and diversify over years rather than being a single destructive event followed by a latent interval.
  • Dravet produces no unilateral hemispheric atrophy and no fixed hemiplegia.
  • SCN1A mutation is found in more than two-thirds of classic Dravet but in only a small minority here.
  • Developmental slowing in Dravet begins in the second year without a discrete injury to date it from.
Show evidence (2 references)
PMID:23916143 SUPPORT Human Clinical
"A role for SCN1A genetic mutations in the development of hemiconvulsion-hemiplegia-epilepsy (HHE) syndrome was recently suggested based on the observation that HHE syndrome and classic Dravet syndrome share many clinical features."
States the clinical overlap that makes this differential necessary, and explains why the two were suspected of sharing a genetic basis.
PMID:23916143 SUPPORT Human Clinical
"We previously identified a 2 bp-deletion mutation in SCN1A in a Dravet patient, and we found out the patient also had HHE syndrome upon clinical re-evaluation."
Documents that a single patient can carry both diagnoses, which is why the separation is drawn on trajectory and imaging rather than on the acute presentation alone.
{ }

Source YAML

click to show 
name: Hemiconvulsion-Hemiplegia-Epilepsy Syndrome
creation_date: "2026-08-05T00:00:00Z"
category: Acquired
description: >-
  A catastrophic sequence that unfolds over hours in a previously well toddler. A
  febrile illness triggers a prolonged convulsive seizure that is clonic and
  one-sided; by the time it stops the child is hemiplegic; the affected
  hemisphere swells acutely and then, over months, shrinks into hemiatrophy; and
  after a latent interval a drug-resistant focal epilepsy emerges from the
  damaged side. The three stages give the syndrome its name. What makes it
  mechanistically arresting is not that a long seizure damages brain, which is
  expected, but that the damage stops at the midline. Nothing in the proposed
  mechanisms explains why an entire hemisphere is taken and the other spared, and
  the authors of the standard review say so outright.
parents:
  - Epilepsy
  - Neurological Disease
synonyms:
  - HHE syndrome
  - HH syndrome
  - hemiconvulsion-hemiplegia syndrome
classifications:
  harrisons_chapter:
    - classification_value: NEUROLOGIC
      notes: >-
        An ILAE-recognized developmental and epileptic encephalopathy of
        childhood, presenting as status epilepticus and managed neurologically.
disease_term:
  preferred_term: idiopathic hemiconvulsion-hemiplegia syndrome
  term:
    id: MONDO:0019485
    label: idiopathic hemiconvulsion-hemiplegia syndrome
mappings:
  mondo_mappings:
    - term:
        id: MONDO:0019485
        label: idiopathic hemiconvulsion-hemiplegia syndrome
      mapping_predicate: skos:exactMatch
      mapping_source: MONDO
      mapping_justification: >-
        MONDO:0019485 is the idiopathic form, which the review literature
        identifies as the commonest reported form and which this entry models as
        its primary subject.
references:
  - reference: PMID:22341151
    title: >-
      Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
  - reference: PMID:35503717
    title: >-
      International League Against Epilepsy classification and definition of
      epilepsy syndromes with onset in childhood: Position paper by the ILAE Task
      Force on Nosology and Definitions.
notes: >-
  Scope note. The MONDO term used here names the idiopathic form, deliberately:
  the review literature reports idiopathic HH/HHE as the commonest form, and
  symptomatic cases, in which a pre-existing lesion or a genetic epilepsy
  predisposes to the prolonged seizure, are modeled here as a predisposing-factor
  node rather than as a separate disease. The two share the cascade from
  prolonged unilateral status onward; what differs is what let the seizure run
  that long.

  On the central gap. This entry curates a mechanism it cannot complete. Each
  step from prolonged febrile seizure through inflammation and blood-brain
  barrier failure to cytotoxic oedema, hemiatrophy, and late epilepsy is
  supported, but none of it explains the syndrome's defining feature, which is
  that the injury respects the midline. The standard review states plainly that
  the proposed factors cannot account for the elective involvement of an entire
  hemisphere. That is recorded as an explicit knowledge gap rather than smoothed
  over with a plausible-sounding chain, and the graph carries a node whose
  content is honestly incomplete.

  Sourcing note. The entry was drafted from the standard review and the clinical
  summaries, then cross-checked against a deep-research report generated with the
  falcon provider (Edison Scientific), committed here as
  research/Hemiconvulsion-Hemiplegia-Epilepsy_Syndrome-deep-research-falcon.md.
  One property of that report shapes how it was used: it states in its own
  evidence-limitations section that direct abstract quotations could not be
  supplied reliably, because most articles on this syndrome were not available as
  searchable full text, and that it therefore omitted PMIDs rather than risk
  supplying incorrect identifiers. That is the right call by the tool, and the
  consequence for curation is that the report was used as a completeness
  cross-check only. No snippet in this entry is taken from it; every quotation
  here comes from a reference fetched and verified against its own cache. The
  report also records that an Open Targets query for this syndrome returned zero
  results, which is itself informative about how little tractable target biology
  exists here.

  Module conformance note. Two nodes conform to
  epilepsy_excitation_inhibition_imbalance, at the hyperexcitability and
  recurrent-seizure nodes. The module's ion-channel trigger is not claimed: the
  proximal event is a prolonged provoked seizure in a normally developing child,
  not a channel defect, and the late epilepsy arises from acquired structural
  damage.
inheritance:
  - name: Not inherited; genetic factors as predisposition only
    description: >-
      The syndrome is acquired, arising from an event rather than a genotype, and
      it is not transmitted. Genetics enters only as one of several factors that
      may let a febrile seizure run long enough to do damage, which puts it
      alongside a focal epileptogenic lesion rather than in a causal role of its
      own. There is no recurrence risk to counsel on in the usual sense.
    inheritance_term:
      preferred_term: Sporadic
      term:
        id: HP:0003745
        label: Sporadic
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          predisposing factors facilitating prolonged seizure such as genetic
          factors or focal epileptogenic lesion
        explanation: >-
          Places genetic factors as predisposing to the prolonged seizure rather
          than causing the syndrome, which is why this block records sporadic
          occurrence with a genetic contribution to susceptibility only.
pathophysiology:
  - name: Predisposing Factors Facilitating Prolonged Seizure
    biological_scale: ORGANISM
    description: >-
      An upstream node covering what makes a particular child's febrile seizure
      run on rather than stop. It is also where the boundary between idiopathic
      and symptomatic cases sits. Two kinds of predisposition are recognized: a
      focal epileptogenic lesion, which in some cases is a mild cortical
      malformation only found after surgery, and genetic factors, for which
      CACNA1A is the one gene the primary literature names in connection with
      this syndrome. This node is deliberately upstream of, and not identical
      with, the status epilepticus itself; it is why some children with prolonged
      febrile seizures develop the syndrome and most do not. It is not a
      necessary node, since the syndrome occurs in children with no identified
      predisposition at all.
    downstream:
      - target: Prolonged Unilateral Febrile Status Epilepticus
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          predisposing factors facilitating prolonged seizure such as genetic
          factors or focal epileptogenic lesion
        explanation: >-
          Names both branches of predisposition explicitly, and frames them as
          facilitating the prolongation of the seizure rather than as causes of
          the syndrome, which is exactly the position this node occupies.
      - reference: PMID:31824410
        reference_title: >-
          Three Cases of Hemiconvulsion-Hemiplegia-Epilepsy Syndrome With Focal
          Cortical Dysplasia Type IIId.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The epileptogenic mild cortical malformations may be the cause of HHES.
        explanation: >-
          The lesional branch made concrete: in three surgical cases the
          predisposing lesion was a focal cortical dysplasia identified only on
          pathology, which is why an initially normal scan does not exclude a
          structural predisposition.
  - name: Prolonged Unilateral Febrile Status Epilepticus
    biological_scale: ORGANISM
    description: >-
      The initiating event, and it is an event rather than a state: a convulsive
      seizure during a febrile illness in a child under about four, clonic and
      predominantly one-sided, which does not stop. Everything that follows is
      downstream of how long it ran. This is also why the syndrome is in principle
      preventable in a way most epilepsies are not, since the damage accrues
      during a window in which someone could be terminating the seizure.
    downstream:
      - target: Inflammation and Blood-Brain Barrier Breakdown
      - target: Unexplained Hemispheric Selectivity
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Hemiconvulsion-Hemiplegia (HH) syndrome is an uncommon consequence of
          prolonged focal febrile convulsive seizures in infancy and early
          childhood.
        explanation: >-
          Names the initiating event and its age window, which is what this node
          models.
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          It is characterized by the occurrence of prolonged clonic seizures with
          unilateral predominance occurring in a child and followed by the
          development of hemiplegia.
        explanation: >-
          Establishes the unilateral predominance of the seizure itself, the first
          appearance of the lateralization this entry cannot explain.
  - name: Inflammation and Blood-Brain Barrier Breakdown
    biological_scale: TISSUE
    description: >-
      Two processes are proposed to convert a long seizure into tissue injury, and
      they reinforce each other. Fever and the underlying illness supply an
      inflammatory context thought to worsen the cell injury a seizure inflicts,
      and inflammation together with sustained ictal activity is proposed to
      compromise the blood-brain barrier. A leaking barrier in a seizing
      hemisphere is a plausible route from electrical activity to the oedema seen
      on imaging. Both remain proposals rather than demonstrations here.
    biological_processes:
      - preferred_term: inflammatory response
        term:
          id: GO:0006954
          label: inflammatory response
        modifier: INCREASED
    downstream:
      - target: Acute Unilateral Cytotoxic Oedema
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          prolonged febrile seizure in which inflammation may worsen the level of
          cell injury; 2. inflammation and prolonged ictal activity that act on
          blood-brain-barrier permeability
        explanation: >-
          States both proposed mechanisms this node models, as contributory factors
          rather than established steps.
  - name: Unexplained Hemispheric Selectivity
    biological_scale: TISSUE
    description: >-
      The node this entry cannot fill, kept explicit rather than hidden. Whatever
      converts a prolonged seizure into injury does so on one side of the brain
      and stops at the midline, and the review that assembles the candidate
      mechanisms concludes that none of them accounts for this. Suggested
      directions include the maturational state of interhemispheric connections,
      the corpus callosum in particular, and genetic factors, but these are
      offered as hypotheses to test rather than answers. Any model of this
      syndrome that does not explain the midline is incomplete, and this one does
      not.
    locations:
      - preferred_term: cerebral hemisphere
        term:
          id: UBERON:0001869
          label: cerebral hemisphere
    downstream:
      - target: Acute Unilateral Cytotoxic Oedema
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          However, these factors cannot explain the elective involvement of an
          entire hemisphere.
        explanation: >-
          The authors' own statement that the assembled mechanisms fail to account
          for the lateralization, which is what this node encodes.
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          We draw new hypothesis that may explain the involvement of one
          hemisphere such as maturation of brain structure such as corpus callosum
          or genetic factors (CACNA1A gene) that are specifically discussed.
        explanation: >-
          Records the proposed directions. Marked PARTIAL because the source
          presents them explicitly as new hypotheses rather than findings.
  - name: Acute Unilateral Cytotoxic Oedema
    biological_scale: TISSUE
    description: >-
      During and immediately after the status epilepticus, imaging shows the
      seizing hemisphere swollen with cytotoxic oedema, meaning water has moved
      into cells that are failing rather than into the interstitium. This is the
      acute radiological signature and the point at which the diagnosis can be
      made rather than inferred in retrospect, which matters because it is also
      the only point at which intervention could plausibly alter the outcome.
    locations:
      - preferred_term: cerebral hemisphere
        term:
          id: UBERON:0001869
          label: cerebral hemisphere
    downstream:
      - target: Hemiplegia
      - target: Progressive Cerebral Hemiatrophy
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Neuroradiological studies showed unilateral edematous swelling of the
          epileptic hemisphere at the time of initial status epilepticus (SE).
        explanation: >-
          Documents the acute swelling and its timing relative to the status
          epilepticus.
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Neuroimaging show unilateral cytotoxic oedema at the initial convulsive
          state, followed by severe chronic atrophy of the affected hemisphere.
        explanation: >-
          Independently confirms the cytotoxic character of the oedema and its
          progression to atrophy.
  - name: Hemiplegia
    biological_scale: ORGANISM
    description: >-
      Weakness of the side opposite the affected hemisphere, present when the
      seizure stops rather than developing later, which distinguishes it from a
      post-ictal Todd paresis that resolves. Its degree varies and it is the
      second element of the syndrome's name.
    evidence:
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Various degrees of hemiplegia and within a variable interval, subsequent
          epilepsia follows.
        explanation: >-
          Documents the variable severity of the hemiplegia and its position before
          the epilepsy.
  - name: Progressive Cerebral Hemiatrophy
    biological_scale: TISSUE
    description: >-
      Over the months after the acute event the swollen hemisphere shrinks, ending
      in severe chronic atrophy of that side alone. The swelling and the atrophy
      are the same process seen at two timepoints, which is why serial imaging is
      more informative than any single scan, and why a scan obtained late shows a
      picture that could be mistaken for a congenital malformation.
    locations:
      - preferred_term: cerebral hemisphere
        term:
          id: UBERON:0001869
          label: cerebral hemisphere
    downstream:
      - target: Epileptogenic Reorganization of the Damaged Hemisphere
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          This acute phase is followed by characteristic cerebral hemiatrophy with
          subsequent appearance of epilepsy, so called
          Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome.
        explanation: >-
          States the progression from acute phase to hemiatrophy to epilepsy, the
          sequence that defines the full syndrome.
  - name: Epileptogenic Reorganization of the Damaged Hemisphere
    biological_scale: CELLULAR
    conforms_to: "epilepsy_excitation_inhibition_imbalance#Seizure Generation and Epileptogenesis"
    description: >-
      Between the hemiatrophy and the epilepsy there is a latent interval, the
      classic signature of epileptogenesis rather than of ongoing seizures: the
      damaged tissue reorganizes into a network that generates seizures, and that
      takes time. The interval is variable, which is part of why the eventual
      epilepsy can seem to arrive out of nowhere in a child whose acute illness
      was months or years earlier.
    downstream:
      - target: Drug-Resistant Focal Epilepsy from the Affected Hemisphere
    evidence:
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Various degrees of hemiplegia and within a variable interval, subsequent
          epilepsia follows.
        explanation: >-
          Documents the latent and variable interval before the epilepsy appears,
          which makes this a reorganization step rather than a direct continuation.
  - name: Drug-Resistant Focal Epilepsy from the Affected Hemisphere
    biological_scale: ORGANISM
    conforms_to: "epilepsy_excitation_inhibition_imbalance#Recurrent Unprovoked Seizures"
    description: >-
      The third element of the name and the reason this is a lifelong diagnosis
      rather than an acute illness. Seizures arise from the atrophic hemisphere
      and are typically refractory to medication, which is what brings these
      children to epilepsy surgery: the damaged side is already largely
      non-functional and the healthy side has had years to take over, so
      disconnection has an unusually favourable ratio of benefit to further loss.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          This acute phase is followed by characteristic cerebral hemiatrophy with
          subsequent appearance of epilepsy, so called
          Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome.
        explanation: >-
          Establishes that the epilepsy is the defining third stage rather than an
          incidental comorbidity.
phenotypes:
  - category: Neurologic
    name: Febrile status epilepticus
    description: >-
      The presenting event: a prolonged convulsive seizure during a febrile
      illness in a child under about four, clonic and predominantly one-sided.
    phenotype_term:
      preferred_term: Status epilepticus
      term:
        id: HP:0002133
        label: Status epilepticus
    evidence:
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome is a rare consequence of a
          status epilepticus in the course of a febrile illness in children under
          the age of four years.
        explanation: >-
          Names the presenting event, its febrile context, and the age window.
  - category: Neurologic
    name: Hemiparesis
    description: >-
      Weakness contralateral to the affected hemisphere, present as the seizure
      ends and persisting, of variable severity.
    phenotype_term:
      preferred_term: Hemiparesis
      term:
        id: HP:0001269
        label: Hemiparesis
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          It is characterized by the occurrence of prolonged clonic seizures with
          unilateral predominance occurring in a child and followed by the
          development of hemiplegia.
        explanation: >-
          Documents the hemiplegia and its position immediately after the seizure.
      - reference: PMID:29414550
        reference_title: >-
          Clinical aspects, neuroimaging, and electroencephalography of 35 cases
          of hemiconvulsion-hemiplegia syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Hemiplegia or spastic hemiparesis of the ipsilateral side to the
          convulsion was present in all patients.
        explanation: >-
          Present in all 35 patients of the largest reported series, which is what
          supports the very frequent band. The source pairs hemiplegia and
          spastic hemiparesis as alternative severities of one deficit, which is
          why the broader Hemiparesis term is retained here while the
          pathophysiology node is named Hemiplegia.
    frequency: VERY_FREQUENT
  - category: Neurologic
    name: Spasticity
    description: >-
      The weakness is characteristically spastic rather than flaccid once the
      acute phase has passed, reflecting loss of descending corticospinal control
      from the destroyed hemisphere.
    phenotype_term:
      preferred_term: Spasticity
      term:
        id: HP:0001257
        label: Spasticity
    evidence:
      - reference: PMID:29414550
        reference_title: >-
          Clinical aspects, neuroimaging, and electroencephalography of 35 cases
          of hemiconvulsion-hemiplegia syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Hemiplegia or spastic hemiparesis of the ipsilateral side to the
          convulsion was present in all patients.
        explanation: >-
          Names the spastic character of the residual weakness in the largest
          reported series.
  - category: Neurologic
    name: Focal-onset seizure
    description: >-
      The late epilepsy is focal, arises from the damaged hemisphere, and is
      typically drug-resistant.
    phenotype_term:
      preferred_term: Focal-onset seizure
      term:
        id: HP:0007359
        label: Focal-onset seizure
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          This acute phase is followed by characteristic cerebral hemiatrophy with
          subsequent appearance of epilepsy, so called
          Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome.
        explanation: >-
          Establishes the epilepsy that follows the hemiatrophy.
  - category: Neurologic
    name: Cerebral hemiatrophy
    description: >-
      Severe chronic atrophy confined to the affected hemisphere, the chronic
      imaging signature and the structural substrate of the later epilepsy.
    phenotype_term:
      preferred_term: Cerebral atrophy
      term:
        id: HP:0002059
        label: Cerebral atrophy
      clinical_course: PROGRESSIVE
    evidence:
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Neuroimaging show unilateral cytotoxic oedema at the initial convulsive
          state, followed by severe chronic atrophy of the affected hemisphere.
        explanation: >-
          Documents the unilateral atrophy and its severity.
prevalence:
  - population: Children with prolonged febrile seizures
    measure_type: UNKNOWN
    prevalence_class: ULTRA_RARE
    notes: >-
      No population-based estimate exists. Both the review literature and the
      clinical summaries describe the syndrome as uncommon or rare among children
      who have prolonged febrile seizures, which is a qualitative statement about
      an already-selected denominator rather than a population rate.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Hemiconvulsion-Hemiplegia (HH) syndrome is an uncommon consequence of
          prolonged focal febrile convulsive seizures in infancy and early
          childhood.
        explanation: >-
          Supports the rarity band against a denominator of children with prolonged
          febrile seizures. Marked PARTIAL because it is a descriptor rather than a
          measurement.
progression:
  - phase: Acute hemiconvulsive status with hemiplegia and hemispheric swelling
    age_range: Under four years
    notes: >-
      The seizure, the hemiplegia, and the unilateral oedema all belong to the
      same acute episode, over hours to days. This is the only phase in which the
      process is plausibly modifiable, which is why early recognition is
      emphasized in every account of the syndrome.
    evidence:
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          To improve the outcome, further studies are needed and early diagnosis
          is essential.
        explanation: >-
          States the emphasis on early diagnosis that this phase turns on.
  - phase: Hemiatrophy and a latent interval, then epilepsy
    age_range: Months to years after the acute event
    notes: >-
      The swollen hemisphere becomes atrophic, and after a variable latent
      interval a drug-resistant focal epilepsy emerges from it. The interval makes
      the causal link easy to miss when a child presents years later with seizures
      and an atrophic hemisphere.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          This acute phase is followed by characteristic cerebral hemiatrophy with
          subsequent appearance of epilepsy, so called
          Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome.
        explanation: >-
          States the sequence of phases this record describes.
genetic:
  - name: CACNA1A
    gene_term:
      preferred_term: CACNA1A
      term:
        id: hgnc:1388
        label: CACNA1A
    relationship_type: SUSCEPTIBILITY
    notes: >-
      The one gene the primary literature names in connection with this syndrome,
      and it is named as a hypothesis about the unexplained hemispheric
      selectivity rather than as an established cause. CACNA1A encodes a neuronal
      calcium channel already implicated in hemiplegic migraine and in
      febrile-seizure-associated phenotypes, which is what makes it a plausible
      candidate for a channel-level predisposition to a prolonged, lateralized
      febrile seizure. It is curated as SUSCEPTIBILITY, not as causative: this is
      not a monogenic disorder, the great majority of cases are sporadic, and no
      cohort has established a CACNA1A variant burden in this syndrome. The
      corresponding open question is carried in the hhe_why_only_one_hemisphere
      discussion.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          We draw new hypothesis that may explain the involvement of one
          hemisphere such as maturation of brain structure such as corpus callosum
          or genetic factors (CACNA1A gene) that are specifically discussed.
        explanation: >-
          The only source-supported naming of a specific gene for this syndrome.
          Marked PARTIAL because the authors present it explicitly as a new
          hypothesis they go on to discuss, not as a demonstrated association.
  - name: SCN1A
    gene_term:
      preferred_term: SCN1A
      term:
        id: hgnc:10585
        label: SCN1A
    relationship_type: SUSCEPTIBILITY
    frequency: rare predisposing cause; 1 of 11 screened patients
    notes: >-
      Included because the negative result is worth curating explicitly. SCN1A
      was a natural candidate, since this syndrome and Dravet syndrome share a
      great deal clinically, both turning on prolonged fever-provoked seizures in
      infancy, and Dravet is more than two-thirds explained by SCN1A. Direct
      sequencing of eleven patients found exactly one mutation, in a patient who
      also met criteria for Dravet, and none in the remaining ten. The reading is
      that SCN1A is a rare predisposing cause rather than the gene of this
      syndrome, and that a child with both an SCN1A mutation and this clinical
      picture may be better understood as having Dravet syndrome with a
      hemiconvulsive presentation. Curating the negative lets the entry say
      affirmatively what it is not: a monogenic sodium channelopathy.
    evidence:
      - reference: PMID:23916143
        reference_title: >-
          Low incidence of SCN1A genetic mutation in patients with
          hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Our study suggests that SCN1A genetic mutation is only a rare
          predisposing cause of HHE syndrome.
        explanation: >-
          The authors' own conclusion, which is precisely the SUSCEPTIBILITY
          rather than causative relationship curated here.
      - reference: PMID:23916143
        reference_title: >-
          Low incidence of SCN1A genetic mutation in patients with
          hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: REFUTE
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Direct sequencing of all coding exons and flanking intronic sequences
          of the SCN1A gene was performed, but we failed to identify additional
          mutations in 10 patients.
        explanation: >-
          Marked REFUTE against the proposition that SCN1A explains this
          syndrome. Ten of eleven patients had no mutation on full coding
          sequencing, which is the direct negative evidence.
treatments:
  - name: Epilepsy surgery, functional hemispherotomy
    description: >-
      For the drug-resistant epilepsy that follows, disconnection of the damaged
      hemisphere. The rationale is unusually clean for epilepsy surgery: the
      seizures arise from a hemisphere that is already destroyed and already
      producing a hemiplegia, so the functional cost of disconnecting it has
      largely been paid by the disease. This is the one intervention that
      addresses the chronic epilepsy at its source rather than suppressing it,
      and in the reported surgical cases it was reached only after antiseizure
      drugs failed.
    therapeutic_modality: SURGERY
    treatment_term:
      preferred_term: Surgical Procedure
      term:
        id: NCIT:C15329
        label: Surgical Procedure
    target_mechanisms:
      - target: Drug-Resistant Focal Epilepsy from the Affected Hemisphere
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:31824410
        reference_title: >-
          Three Cases of Hemiconvulsion-Hemiplegia-Epilepsy Syndrome With Focal
          Cortical Dysplasia Type IIId.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Their seizures were intractable with antiepileptic drugs and required
          hemispherotomy.
        explanation: >-
          Establishes both that the epilepsy is drug-resistant and that
          hemispherotomy is the intervention it is escalated to.
  - name: Aggressive termination of the status epilepticus
    description: >-
      The one intervention with a mechanistic claim on the outcome, because the
      injury accrues while the seizure runs. Everything else in this entry treats
      consequences. The corollary is uncomfortable and worth stating: by the time
      the syndrome is recognizable as itself, the treatable window has usually
      closed, which is why the literature stresses early diagnosis rather than
      novel therapy.
    therapeutic_modality: SMALL_MOLECULE
    treatment_term:
      preferred_term: Pharmacotherapy
      term:
        id: NCIT:C15986
        label: Pharmacotherapy
    target_mechanisms:
      - target: Prolonged Unilateral Febrile Status Epilepticus
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          To improve the outcome, further studies are needed and early diagnosis
          is essential.
        explanation: >-
          Supports the emphasis on acting early. Marked PARTIAL because it calls
          for early diagnosis and further study rather than demonstrating that any
          particular acute treatment changes the outcome, which is the honest state
          of the evidence.
      - reference: PMID:29414550
        reference_title: >-
          Clinical aspects, neuroimaging, and electroencephalography of 35 cases
          of hemiconvulsion-hemiplegia syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          On the one hand, authors highlight the need for improving emergency
          care of status epilepticus.
        explanation: >-
          A recommendation about status epilepticus management specifically,
          rather than about the syndrome in general, which is what this treatment
          record asserts.
  - name: Prophylaxis of febrile seizures
    description: >-
      Upstream of everything else. Because the syndrome is the consequence of a
      prolonged febrile seizure, preventing or shortening febrile seizures
      prevents the syndrome outright, and in settings where emergency care of
      status epilepticus is hard to deliver reliably this is argued to be the
      more realistic lever of the two. That is a statement about health systems
      as much as about biology, and the source makes it in exactly those terms.
    therapeutic_modality: BEHAVIORAL
    treatment_term:
      preferred_term: Supportive Care
      term:
        id: NCIT:C15747
        label: Supportive Care
    target_mechanisms:
      - target: Prolonged Unilateral Febrile Status Epilepticus
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:29414550
        reference_title: >-
          Clinical aspects, neuroimaging, and electroencephalography of 35 cases
          of hemiconvulsion-hemiplegia syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          On the other hand, in our context, the prophylaxis of febrile seizures
          seems to be the corner stone of the prevention of HHE Syndrome.
        explanation: >-
          Names febrile-seizure prophylaxis as the cornerstone of prevention, and
          scopes the claim to the authors' own setting, which is why the
          description keeps that qualification.
  - name: Antiseizure medication for the established epilepsy
    description: >-
      Medication is used for the late focal epilepsy and frequently fails, which
      is what brings these children to surgical assessment. Its role is symptom
      control rather than modification of the underlying damage, which is fixed by
      the time it is prescribed.
    therapeutic_modality: SMALL_MOLECULE
    treatment_term:
      preferred_term: Pharmacotherapy
      term:
        id: NCIT:C15986
        label: Pharmacotherapy
    target_mechanisms:
      - target: Drug-Resistant Focal Epilepsy from the Affected Hemisphere
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          understanding of the underlying mechanisms of HHE are needed to improve
          the outcome of this condition
        explanation: >-
          Supports the position that outcomes are currently unsatisfactory and
          depend on mechanistic understanding not yet available. Marked PARTIAL
          because it speaks to the state of the field rather than to the efficacy
          of any drug.
diagnosis:
  - name: Brain MRI, acute and serial
    description: >-
      Imaging is what makes the diagnosis, and the timing changes what it shows.
      Acutely the affected hemisphere is swollen with cytotoxic oedema; months
      later the same hemisphere is atrophic. A single late scan can therefore be
      misread as a congenital or long-standing abnormality, which is an argument
      for imaging during the acute illness rather than only afterwards.
    diagnosis_term:
      preferred_term: Magnetic Resonance Imaging
      term:
        id: NCIT:C16809
        label: Magnetic Resonance Imaging
    results: >-
      Unilateral hemispheric swelling with cytotoxic oedema acutely; severe
      unilateral hemiatrophy on later imaging.
    evidence:
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Neuroimaging show unilateral cytotoxic oedema at the initial convulsive
          state, followed by severe chronic atrophy of the affected hemisphere.
        explanation: >-
          States both imaging appearances and their timing, which is the content of
          the results field.
  - name: Electroencephalography
    description: >-
      Electroencephalography documents the lateralized ictal activity during the
      acute episode and later characterizes the focal epilepsy arising from the
      damaged hemisphere, which is the information a surgical assessment needs.
    diagnosis_term:
      preferred_term: Electroencephalography
      term:
        id: NCIT:C38054
        label: Electroencephalography
    results: >-
      Lateralized ictal activity acutely; later, focal epileptiform abnormality
      over the atrophic hemisphere.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Neuroradiological studies showed unilateral edematous swelling of the
          epileptic hemisphere at the time of initial status epilepticus (SE).
        explanation: >-
          Establishes that the hemisphere involved is the epileptic one, which is
          the lateralization electroencephalography demonstrates. Marked PARTIAL
          because the quoted sentence reports imaging rather than electrographic
          findings.
differential_diagnoses:
  - name: Rasmussen Encephalitis
    disease_term:
      preferred_term: Rasmussen subacute encephalitis
      term:
        id: MONDO:0016019
        label: Rasmussen subacute encephalitis
    description: >-
      The other childhood syndrome that destroys one hemisphere and leaves a
      drug-resistant epilepsy, and the closest mimic on a late scan. The
      distinction is tempo: here the damage is done in a single acute episode and
      then stops, whereas Rasmussen is a progressive inflammatory process that
      keeps consuming the hemisphere over years.
    distinguishing_features:
      - Damage is inflicted in one acute episode rather than accruing progressively over years.
      - Onset is a febrile status epilepticus, not an insidious increase in seizure frequency.
      - Hemiplegia appears at the outset rather than developing as the hemisphere is progressively lost.
      - No histological evidence of ongoing T-cell-mediated encephalitis.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          This acute phase is followed by characteristic cerebral hemiatrophy with
          subsequent appearance of epilepsy, so called
          Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome.
        explanation: >-
          Establishes the monophasic acute-then-atrophy course that distinguishes
          this syndrome from a progressive encephalitis producing the same endpoint.
  - name: Dravet Syndrome
    disease_term:
      preferred_term: Dravet syndrome
      term:
        id: MONDO:0100135
        label: Dravet syndrome
    description: >-
      Arguably the most consequential differential, because the two syndromes
      share the thing that defines this one: prolonged, often hemiclonic,
      fever-provoked seizures in the first years of life. The overlap is close
      enough that it motivated screening this syndrome for SCN1A in the first
      place, and close enough that a child can satisfy both descriptions. The
      separation matters because Dravet is a monogenic channelopathy with its own
      trajectory and its own contraindicated drugs, whereas this syndrome is an
      acquired hemispheric injury.
    distinguishing_features:
      - Seizures in Dravet recur and diversify over years rather than being a single destructive event followed by a latent interval.
      - Dravet produces no unilateral hemispheric atrophy and no fixed hemiplegia.
      - SCN1A mutation is found in more than two-thirds of classic Dravet but in only a small minority here.
      - Developmental slowing in Dravet begins in the second year without a discrete injury to date it from.
    evidence:
      - reference: PMID:23916143
        reference_title: >-
          Low incidence of SCN1A genetic mutation in patients with
          hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          A role for SCN1A genetic mutations in the development of
          hemiconvulsion-hemiplegia-epilepsy (HHE) syndrome was recently
          suggested based on the observation that HHE syndrome and classic Dravet
          syndrome share many clinical features.
        explanation: >-
          States the clinical overlap that makes this differential necessary, and
          explains why the two were suspected of sharing a genetic basis.
      - reference: PMID:23916143
        reference_title: >-
          Low incidence of SCN1A genetic mutation in patients with
          hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          We previously identified a 2 bp-deletion mutation in SCN1A in a Dravet
          patient, and we found out the patient also had HHE syndrome upon
          clinical re-evaluation.
        explanation: >-
          Documents that a single patient can carry both diagnoses, which is why
          the separation is drawn on trajectory and imaging rather than on the
          acute presentation alone.
  - name: Febrile Infection-Related Epilepsy Syndrome
    disease_term:
      preferred_term: febrile infection-related epilepsy syndrome
      term:
        id: MONDO:0015584
        label: febrile infection-related epilepsy syndrome
    description: >-
      Classified by the ILAE alongside this syndrome and sharing the essential
      setup, a febrile illness in a previously well child followed by refractory
      status and then chronic epilepsy. The separation is topographic: FIRES is
      bilateral and diffuse, this syndrome takes one hemisphere.
    distinguishing_features:
      - Status epilepticus is bilateral and refractory rather than unilateral and clonic.
      - No hemiplegia and no unilateral hemiatrophy.
      - Onset typically in school-age children rather than under four.
    evidence:
      - reference: PMID:35503717
        reference_title: >-
          International League Against Epilepsy classification and definition of
          epilepsy syndromes with onset in childhood: Position paper by the ILAE
          Task Force on Nosology and Definitions.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          developmental and/or epileptic encephalopathies, comprising five
          syndromes: epilepsy with myoclonic-atonic seizures, Lennox-Gastaut
          syndrome, developmental and/or epileptic encephalopathy with
          spike-and-wave activation in sleep, hemiconvulsion-hemiplegia-epilepsy
          syndrome, and febrile infection-related epilepsy syndrome.
        explanation: >-
          Establishes that the ILAE treats these as two distinct syndromes within
          the same category, which is what makes the differentiation necessary.
discussions:
  - discussion_id: hhe_why_only_one_hemisphere
    kind: KNOWLEDGE_GAP
    status: OPEN
    prompt: >-
      Every proposed mechanism for this syndrome, prolonged seizure activity,
      inflammation, blood-brain barrier failure, is bilateral in principle. Why
      does the injury take one entire hemisphere and stop at the midline?
    attaches_to:
      - pathophysiology#Unexplained Hemispheric Selectivity
      - pathophysiology#Acute Unilateral Cytotoxic Oedema
    rationale: >-
      This is the defining feature of the syndrome and the one thing no account of
      it explains. The review that assembles the candidate mechanisms says so
      directly: the factors it lists cannot explain the elective involvement of an
      entire hemisphere. The difficulty is structural rather than evidential.
      Prolonged seizure activity, fever, systemic inflammation, and barrier
      permeability are all whole-brain phenomena, so none has the geometry to
      produce a lesion bounded by the midline. Something must supply the
      lateralization, and the candidates fall into three families. It could
      originate in the seizure itself, if the discharge stays confined to one
      hemisphere because interhemispheric propagation is limited in the immature
      brain, which is where the corpus callosum hypothesis comes from and which
      would make this a disease of a developmental window rather than of any
      particular insult. It could be vascular or metabolic, if unilateral
      hyperperfusion or a unilateral failure of autoregulation determines which
      side decompensates. Or the child could carry a pre-existing asymmetry,
      subtle enough to be invisible on imaging, that makes one hemisphere both
      likelier to sustain the seizure and likelier to be injured by it. That last
      branch is the one with a named molecular candidate: the same review that
      raises these hypotheses points specifically at CACNA1A, a neuronal calcium
      channel gene already tied to hemiplegic migraine, as the genetic factor
      worth pursuing. It is curated in the genetic section as SUSCEPTIBILITY
      rather than as a cause, because it has been proposed and discussed but
      never tested in a cohort with this syndrome, and a channel-level
      predisposition is only one of several routes to a pre-existing asymmetry.
      The lesional counterpart of the same branch is concrete rather than
      hypothetical: three surgical cases turned out to have a focal cortical
      dysplasia that no scan had shown. These make
      different predictions and none has been tested head to head. The stake is
      practical as well as intellectual: if lateralization is set by the seizure's
      propagation, then interrupting propagation early is protective, whereas if
      it reflects a pre-existing asymmetry, the die is cast before the child ever
      seizes.
    proposed_experiments:
      - experiment_id: exp_hhe_acute_lateralization_imaging_cohort
        name: Acute multimodal imaging in prolonged unilateral febrile status
        description: >-
          Prospectively image children presenting with prolonged lateralized
          febrile status during the acute episode, combining perfusion imaging,
          diffusion, and barrier-permeability sequences over both hemispheres, and
          follow them for the development of hemiatrophy and epilepsy. The
          unaffected hemisphere is the internal control the retrospective
          literature never has.
        decision_criterion: >-
          If the hemispheres differ in perfusion or barrier permeability before
          oedema is established, the lateralization is haemodynamic or vascular and
          is potentially modifiable acutely. If the two are indistinguishable until
          oedema appears, the determinant lies upstream in seizure propagation or
          in a pre-existing asymmetry.
      - experiment_id: exp_hhe_callosal_maturation_comparison
        name: Callosal maturation in affected children versus matched febrile status controls
        description: >-
          Compare corpus callosum size and diffusion metrics between children who
          developed the syndrome and age-matched children who had prolonged febrile
          status without it, using imaging obtained as close to the event as
          possible.
        decision_criterion: >-
          A systematic difference in callosal maturation would support the
          interhemispheric-propagation hypothesis and would predict that the age
          window of the syndrome tracks callosal development. No difference would
          effectively close that line and redirect attention to vascular and
          pre-existing-asymmetry accounts.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          However, these factors cannot explain the elective involvement of an
          entire hemisphere.
        explanation: >-
          The explicit statement that the assembled mechanisms fail on the
          syndrome's defining feature, which makes this a genuine gap rather than a
          curator's doubt.
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          We draw new hypothesis that may explain the involvement of one
          hemisphere such as maturation of brain structure such as corpus callosum
          or genetic factors (CACNA1A gene) that are specifically discussed.
        explanation: >-
          Names the interhemispheric-maturation and genetic directions that two of
          the proposed experiments are designed to separate.
      - reference: PMID:25534340
        reference_title: Hemiconvulsion-hemiplegia-epilepsy syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          The aetiology remains unclear. Several mechanisms may contribute to this
          condition. To improve the outcome, further studies are needed and early
          diagnosis is essential.
        explanation: >-
          Independent confirmation from a separate summary that the cause is
          unresolved and plural rather than settled, which is why this is curated
          as an open gap rather than a contested one.
  - discussion_id: hhe_immature_brain_resistance_paradox
    kind: CONTROVERSY
    status: UNDER_DISCUSSION
    prompt: >-
      Experimental work indicates the immature brain resists seizure-induced cell
      injury, yet this syndrome destroys a hemisphere precisely in that age group.
      Is the animal evidence not transferable, or is the human injury produced by
      something other than the seizure itself?
    attaches_to:
      - pathophysiology#Inflammation and Blood-Brain Barrier Breakdown
      - pathophysiology#Acute Unilateral Cytotoxic Oedema
    rationale: >-
      The review states that basic science data suggest the immature brain is
      relatively resistant to injury from status epilepticus. Taken at face value
      that is in direct tension with a syndrome whose entire clinical content is
      catastrophic injury from status epilepticus in children under four. Three
      readings are available. The first treats it as a translation failure: rodent
      models of status may not reproduce the human situation, and the resistance
      seen experimentally may not hold for a seizure of this duration in a febrile
      child. The second, which the review's own emphasis points toward, is that
      the seizure alone is not what does the damage; the injury requires the
      inflammatory context of the febrile illness, and the resistant immature
      brain becomes vulnerable only when inflammation and barrier breakdown are
      added. That reading is attractive because it explains why the syndrome
      follows febrile status specifically rather than status of any cause, and it
      makes fever a mechanistic participant rather than a trigger. The third is
      that the resistance is real and the syndrome occurs only in the minority of
      children in whom some additional factor overrides it, which converts the
      question into one about predisposition. Distinguishing these matters for
      whether anti-inflammatory treatment during the acute episode is worth
      studying, which on the second reading it clearly would be and on the first
      and third much less so.
    proposed_experiments:
      - experiment_id: exp_hhe_inflammatory_markers_in_febrile_status
        name: Inflammatory profiling in prolonged febrile status with and without the syndrome
        description: >-
          Measure serum and cerebrospinal fluid inflammatory markers during
          prolonged febrile status epilepticus in children, and compare those who
          go on to develop hemiplegia and hemiatrophy with those who recover
          without sequelae, matched for seizure duration.
        decision_criterion: >-
          A higher inflammatory burden in those who develop the syndrome, at
          matched seizure duration, would support inflammation as the necessary
          co-factor and would make acute immunomodulation a rational thing to
          trial. Comparable inflammation with outcome tracking seizure duration
          alone would place the weight back on the seizure and on how fast it is
          stopped.
    evidence:
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          The basic science data suggest that immature brain is relatively
          resistant to SE-induced cell injury.
        explanation: >-
          States the experimental finding that stands in tension with the clinical
          syndrome. Tagged MODEL_ORGANISM because the resistance is a basic-science
          result rather than a human observation, which is itself the first
          interpretation this discussion weighs.
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          prolonged febrile seizure in which inflammation may worsen the level of
          cell injury; 2. inflammation and prolonged ictal activity that act on
          blood-brain-barrier permeability
        explanation: >-
          States the inflammatory co-factor reading, the second and most actionable
          of the three interpretations weighed here.
      - reference: PMID:22341151
        reference_title: >-
          Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          predisposing factors facilitating prolonged seizure such as genetic
          factors or focal epileptogenic lesion
        explanation: >-
          Supports the predisposition reading. Marked PARTIAL because these factors
          are offered as facilitating the prolonged seizure rather than overriding a
          resistance to injury, so they bear on the third interpretation only
          indirectly.
📚

References & Deep Research

References

2
PMID:22341151
Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings.
No top-level findings curated for this source.
PMID:35503717
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.
No top-level findings curated for this source.

Deep Research

1
Falcon ▸
Hemiconvulsion–Hemiplegia–Epilepsy Syndrome: Disease-Characteristics Report
Edison Scientific Literature 17 citations 2026-08-05T18:26:07.121148

Hemiconvulsion–Hemiplegia–Epilepsy Syndrome: Disease-Characteristics Report

Executive summary

Hemiconvulsion–hemiplegia–epilepsy (HHE) syndrome is a rare, acquired, predominantly pediatric destructive encephalopathy/epilepsy syndrome. Its defining sequence is: (1) prolonged unilateral clonic status epilepticus, usually during fever; (2) immediate or early persistent contralateral hemiplegia; and (3) delayed focal epilepsy, often accompanied by unilateral cerebral atrophy. The evidence base remains limited mainly to retrospective cohorts, imaging series, surgical series, and case reports; there are no disease-specific randomized trials, validated molecular biomarkers, or robust population incidence estimates.

Open Targets recognizes the related entity “idiopathic hemiconvulsion-hemiplegia syndrome,” MONDO:0019485, but lists zero associated targets, consistent with the syndrome not having an established single molecular cause. The exact ontology boundary between hemiconvulsion–hemiplegia syndrome and full HHE syndrome should be checked in each resource before automated cross-mapping. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome)

Domain Established finding Evidence type / key study and year Ontology suggestions Confidence or gap
Disease definition Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome is an acquired pediatric epilepsy-related syndrome characterized by a stereotyped sequence: prolonged unilateral convulsive status, followed by persistent hemiplegia, then later focal epilepsy; Open Targets lists a related entity as “idiopathic hemiconvulsion-hemiplegia syndrome.” (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) Disease knowledgebase context: Open Targets disease entry; classic syndrome literature exists but was not available in current tool context (2024 Open Targets context) (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) MONDO: related entity present but exact HHE mapping uncertain; NCIT: epilepsy syndrome term uncertain; HPO: Hemiconvulsion/Hemiplegia/Epilepsy terms applicable, exact IDs not verified Moderate confidence for broad definition; exact ontology crosswalk for classic HHE remains uncertain in available context
Classification / origin The syndrome is best treated as acquired rather than monogenic, because the defining event is an acute destructive hemispheric injury associated with status epilepticus and subsequent cerebral hemiatrophy. Human clinical syndrome literature cited by search results (Auvin 2012 review; Gastaut 1959; case series), but full text not available in current context MONDO/Orphanet mapping uncertain; HPO suggestion: acquired cerebral hemiatrophy, hemiparesis, focal seizures Moderate confidence; primary evidence not fully extracted in tool context
Acute trigger sequence Typical presentation is prolonged febrile hemiclonic status epilepticus in infancy/early childhood, often after a febrile illness, preceding unilateral brain injury. Human clinical reviews/case series identified by search: Tenney 2012; Auvin 2012; South African series 2012; exact extracted text unavailable HPO: Febrile seizure term, Status epilepticus term, Clonic seizure term, Focal motor seizure term Moderate confidence; exact percentages and onset distributions are a current data gap
Core neurologic deficit Persistent contralateral hemiplegia/hemiparesis follows the acute hemiconvulsive episode and is a defining phenotype. Human clinical syndrome literature identified in searches; not directly extracted HPO: Hemiparesis; Hemiplegia; Motor developmental impairment if chronic High confidence for phenotype, low confidence for frequency estimates
Epilepsy evolution Delayed epilepsy commonly emerges after the acute hemiplegic phase, usually as chronic focal drug-resistant epilepsy in a subset of survivors. Human longitudinal/surgical literature identified by search, including Kim et al. 2008 on delayed epilepsy surgery HPO: Focal-onset seizure; Drug-resistant epilepsy; Developmental regression/cognitive impairment if present Moderate confidence; exact latency and response rates not available in current context
Neuroimaging Characteristic imaging pattern: acute unilateral hemispheric edema/swelling with diffusion restriction, followed over time by hemispheric atrophy/hemiatrophy and gliosis. Human MRI/pathology studies identified in searches: Freeman 2002; Toldo 2007; Auvin 2007; Barcia 2013; exact text not extracted UBERON: cerebral hemisphere; HPO: Cerebral hemiatrophy, Cerebral edema, Abnormal brain MRI; GO CC not specifically applicable High confidence for qualitative MRI sequence; numerical timing details remain a gap
Electrophysiology EEG is used to document focal hemispheric seizure activity acutely and later focal epileptiform abnormalities, but no syndrome-specific EEG biomarker is established. Human clinical literature and epilepsy reviews; no dedicated biomarker evidence retrieved HPO: Abnormal EEG; Focal epileptiform discharges (exact term ID unverified) Moderate confidence; syndrome-specific EEG signatures are not well standardized
Pathology / mechanism Available pathology literature supports inflammatory-degenerative hemispheric injury after prolonged seizures, with mechanistic hypotheses centered on excitotoxicity, cytotoxic edema, blood-brain barrier dysfunction, and secondary inflammation rather than a single causal gene. Human pathology case reports/reviews identified by search (Auvin 2007; Serino 2014) plus general mechanistic support from seizure/brain-injury literature found in context GO: excitatory neurotransmission, neuroinflammatory response, cell death, response to hypoxia; CL: cortical neuron, astrocyte, microglial cell Moderate confidence; direct HHE molecular studies are sparse
Genetics SCN1A variants have been reported only in a minority of HHE cases; the available literature supports “low incidence” and argues HHE is not a typical monogenic SCN1A disorder. Human genetics study identified by search: Kim et al. 2013, “Low incidence of SCN1A genetic mutation in patients with hemiconvulsion–hemiplegia–epilepsy syndrome” HGNC: SCN1A; HPO: Seizures precipitated by fever may overlap with Dravet-spectrum phenotypes Moderate-to-high confidence for “not monogenic/low incidence”; exact mutation counts not available in current context
Differential diagnosis Important differentials include Dravet syndrome/GEFS+ spectrum, FIRES/NORSE, Rasmussen encephalitis, stroke, alternating hemiplegia, encephalitis/encephalopathy, and structural or metabolic disorders causing unilateral edema and subsequent atrophy. Human review literature identified by search; current tool context does not provide extracted differential tables HPO overlap terms: hemiplegia, focal seizures, fever-associated seizures; MONDO terms uncertain Moderate confidence; evidence synthesis limited by unavailable full texts
Management Acute management is supportive neurocritical care plus standard status epilepticus treatment; chronic management includes antiseizure medications, rehabilitation, and evaluation for epilepsy surgery in medically refractory cases. Human clinical reviews/case reports identified by search; no dedicated interventional trials retrieved NCIT suggestions: anticonvulsant therapy, physical therapy, occupational therapy, epilepsy surgery/hemispherectomy (exact NCIT IDs unverified) High confidence for real-world practice pattern; low confidence for comparative efficacy data
Surgical treatment In selected patients with delayed refractory epilepsy and a functionally devastated hemisphere, hemispherectomy/hemispherotomy has been reported as a real-world treatment option with seizure benefit in case series. Human surgical series identified by search: Kim et al. 2008; later hemispherectomy experience papers also identified NCIT: Hemispherectomy / Hemispherotomy term uncertain; HPO: post-surgical seizure reduction not an HPO phenotype Moderate confidence; no randomized evidence
Epidemiology HHE is rare; the literature consists mainly of case reports, small series, and retrospective cohorts, with no robust population incidence estimate retrieved in current context. Search results include small retrospective series (e.g., 35 cases, 10 cases, regional case series), but no population registry evidence extracted MONDO/Orphanet prevalence term uncertain High confidence that disease is rare; major quantitative epidemiology gap
Recent developments (2023-2024) Recent searchable material is dominated by isolated case reports and broader epilepsy classification updates; no major 2023-2024 breakthrough mechanistic, genomic, or therapeutic trial program was retrieved. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) Search evidence and Open Targets show no disease-target associations in the retrieved context. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) Open Targets disease-target links absent; omics ontology suggestions not applicable High confidence for evidence sparsity
Trials / translational research No dedicated interventional clinical trials were retrieved for HHE; no disease-specific target program or drug-development signal was found in Open Targets. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) ClinicalTrials search: no relevant dedicated trial retrieved; Open Targets associatedTargets count = 0. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) NCIT: clinical trial not disease-specific; Open Targets disease-target association absent High confidence for lack of dedicated trial/target evidence
Omics / biomarkers No HHE-specific transcriptomic, proteomic, metabolomic, spatial, or single-cell studies were retrieved; no validated circulating biomarker or molecular diagnostic signature was identified. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) Evidence gap from tool searches and Open Targets context. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) GO/CL/omics terms not disease-specific; biomarker ontology mapping unavailable High confidence that this is a major knowledge gap

Table: This table summarizes the most actionable disease-knowledge findings for Hemiconvulsion-Hemiplegia-Epilepsy syndrome and explicitly marks where evidence is based on classic clinical literature versus current gaps. It is useful for rapid knowledge-base curation because it links core syndrome features to ontology suggestions and highlights missing trials, targets, and omics data.

1. Disease information

Definition and classification

HHE is an acquired sequence rather than a conventional inherited epilepsy syndrome. The initial “hemiconvulsion” is prolonged focal motor—usually hemiclonic—status epilepticus. It produces or accompanies acute unilateral hemispheric injury, after which the child has contralateral hemiplegia or severe hemiparesis. Chronic focal epilepsy may emerge after a latent interval.

The term hemiconvulsion–hemiplegia (HH) syndrome is appropriately used before recurrent unprovoked epilepsy appears; HHE syndrome denotes completion of the three-stage sequence. “Idiopathic” historically indicated absence of a demonstrable antecedent structural lesion, infection, or metabolic disorder, not proof of a primary genetic disease.

Identifiers and synonyms

Resource Suggested entry or status
MONDO MONDO:0019485, “idiopathic hemiconvulsion-hemiplegia syndrome”; verify whether the intended record includes the delayed-epilepsy stage (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome)
Orphanet Search under hemiconvulsion-hemiplegia-epilepsy syndrome and idiopathic hemiconvulsion-hemiplegia syndrome; an ORPHA number could not be reliably verified from the retrieved evidence
OMIM No well-established standalone Mendelian HHE phenotype was verified
ICD-10 No specific HHE code; code constituent diagnoses, such as status epilepticus, focal epilepsy, and hemiplegia, according to local coding rules
ICD-11 No disease-specific code verified; use the relevant epilepsy/status and acquired motor-deficit categories
MeSH No dedicated MeSH descriptor verified; use Epilepsy, Status Epilepticus, Hemiplegia, Seizures, Febrile, and Brain Atrophy

Synonyms: HHE syndrome; hemiconvulsion–hemiplegia–epilepsy syndrome; hemiconvulsion–hemiplegia syndrome; HH syndrome; idiopathic hemiconvulsion–hemiplegia syndrome; infantile hemiconvulsion–hemiplegia and epilepsy syndrome; historically, hemiplegia–hemiconvulsion–epilepsy syndrome.

Data provenance

The description is derived from aggregated disease-level literature, including small retrospective cohorts and imaging series—not from a single patient’s EHR. Major sources include the classic description by Gastaut et al. (1959), the review by Auvin et al. (published September 2012; DOI), and the 35-patient clinical/imaging/EEG series by Albakaye et al. (published March 2018; DOI).

2. Etiology

Primary causal factors

The proximate trigger is generally prolonged unilateral status epilepticus in the immature brain, frequently associated with fever or an acute infection. HHE can also occur in association with pre-existing structural, metabolic, inflammatory, or genetic neurologic disease; such cases are better described as secondary HHE phenotypes.

Reported associations include CNS or systemic infection, congenital adrenal hyperplasia, L-2-hydroxyglutaric aciduria, tuberous sclerosis complex, 1q44 deletion, leukodystrophy, and Dravet syndrome. These heterogeneous associations support HHE as a final common clinicoradiologic pathway, not a unitary etiologic disease.

Risk factors

  • Age: infancy and early childhood, when fever-provoked seizures and the immature brain’s susceptibility to excitotoxic edema are greatest.
  • Seizure duration and refractoriness: prolonged focal motor status is the most consistent modifiable risk factor.
  • Hyperthermia/fever: likely lowers seizure threshold and may amplify seizure-mediated metabolic injury. Experimental work shows that hyperthermia aggravates epileptic brain injury, whereas hypothermia reduces it; this is supportive animal evidence, not HHE-specific clinical proof (Lundgren et al., DOI).
  • Underlying neurologic disease: structural lesions, metabolic disorders, encephalitis/encephalopathy, or developmental and epileptic encephalopathies can predispose to the same sequence.
  • SCN1A: variants occur in a minority of reported HHE patients and can indicate a Dravet-spectrum phenotype rather than primary HHE. Kim et al. explicitly reported a “low incidence of SCN1A genetic mutation” (published October 2013; DOI).

No reproducible sex, ancestry, lifestyle, toxin, occupational, smoking, alcohol, or dietary risk factor has been established.

Protective factors

No validated protective allele, diet, supplement, or long-term prophylactic drug has been demonstrated. The most biologically plausible protection is rapid termination of prolonged seizures, maintenance of oxygenation, perfusion, glucose, electrolytes, and normothermia, and prompt treatment of infection. These are standards of status-epilepticus care rather than HHE-specific trial results.

Gene–environment interaction

A reasonable model is that genetic seizure susceptibility—particularly an SCN1A-related fever-sensitive epilepsy or another developmental epilepsy—interacts with fever and prolonged status to cross a threshold for unilateral excitotoxic injury. This remains a susceptibility model; there is no validated polygenic score, modifier locus, or quantified interaction effect.

3. Phenotypes

Phenotype Type, onset, course, severity Suggested HPO term
Prolonged unilateral clonic seizure/status Acute in infancy/early childhood; severe and often fever-associated; defining initial event Focal motor seizure HP:0011153; Status epilepticus HP:0002133; Febrile seizures HP:0002373
Hemiplegia/hemiparesis Appears during or immediately after status; contralateral to injured hemisphere; persistent, sometimes improving from plegia to paresis Hemiplegia HP:0002301; Hemiparesis HP:0001269
Delayed focal epilepsy Develops after a variable latent period; chronic; may be drug resistant Focal seizures HP:0007359; Refractory epilepsy HP:0002345
Acute unilateral cerebral edema and restricted diffusion Early MRI sign; severe and evolving Cerebral edema HP:0002181; Abnormal brain MRI HP:0410263
Cerebral hemiatrophy/gliosis Chronic consequence, unilateral and usually ipsilateral to the original seizures Cerebral atrophy HP:0002059; Cerebral cortical atrophy HP:0002120
Intellectual/developmental impairment Variable; reflects age, lesion extent, status severity, recurrent epilepsy, and underlying cause Global developmental delay HP:0001263; Intellectual disability HP:0001249
Language impairment Common when the dominant hemisphere is injured or epilepsy remains active Delayed speech and language development HP:0000750
Unilateral spasticity, contracture, gait impairment Chronic corticospinal consequence Spasticity HP:0001257; Abnormal gait HP:0001288
Visual-field deficit Possible with posterior hemispheric injury Homonymous hemianopia HP:0002159

Reliable phenotype percentages cannot be generalized: by definition, hemiconvulsion and hemiplegia are near-obligate, whereas delayed epilepsy, cognitive impairment, language deficit, and drug resistance vary substantially among small and selected cohorts.

Quality of life

Persistent unilateral weakness affects ambulation, bimanual activity, dressing, feeding, school participation, and independence. Chronic epilepsy adds medication burden, injury risk, supervision requirements, and psychosocial stress. Cognitive and language impairment may dominate educational outcome. No HHE-specific EQ-5D, PROMIS, SF-36, or validated disease-specific quality-of-life study was identified.

4. Genetic and molecular information

HHE has no established defining causal gene, inheritance pattern, penetrance estimate, carrier frequency, founder variant, or recurrent pathogenic chromosomal abnormality. Open Targets reports no disease-associated target for the mapped idiopathic HH entity. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome)

Reported genetic findings

  • SCN1A—HGNC:10585; OMIM gene 182389—has been investigated because prolonged fever-triggered hemiclonic seizures are characteristic of Dravet syndrome. Variants are uncommon in clinically diagnosed HHE and should prompt reassessment for a Dravet-spectrum disorder.
  • 1q44 microdeletion has been described in a single HHE case; causality was explicitly uncertain (Gupta et al., January 2014).
  • Individual secondary cases associated with monogenic/metabolic disorders do not establish those genes as causes of idiopathic HHE.

There are no HHE-specific curated variant lists, recurrent pathogenic alleles, allele-frequency estimates, somatic drivers, established modifier genes, epigenetic signatures, methylation episignatures, or chromosomal hotspots. Variant classification should therefore be assigned to the underlying diagnosed genetic disease, not to HHE itself.

5. Environmental information

Fever and acute infection are common seizure precipitants. Reported infections include routine febrile illnesses and isolated cases associated with influenza, HHV-6-related illness, and COVID-19/multisystem inflammatory syndrome. Infection may act through fever, cytokine signaling, altered blood–brain-barrier function, or direct encephalitis; pathogen detection does not automatically establish direct brain infection.

No consistent role is established for pollution, radiation, pesticides, heavy metals, occupation, smoking, alcohol, exercise, or nutrition. Lifestyle variables are largely inapplicable because onset usually occurs in very young children.

6. Mechanism and pathophysiology

Proposed causal chain

  1. Upstream trigger: fever/infection or another acute cerebral stressor in a susceptible young child.
  2. Prolonged unilateral seizure activity: sustained excitatory firing markedly increases ATP and oxygen demand.
  3. Ionic and transmitter failure: glutamate-dependent excitation, sodium and calcium entry, potassium disequilibrium, and impaired Na⁺/K⁺-ATPase activity produce cytotoxic edema.
  4. Neurovascular dysfunction: hyperperfusion may initially compensate, but autoregulatory failure, blood–brain-barrier disruption, vasogenic edema, and relative hypoxia/ischemia can follow.
  5. Secondary injury: mitochondrial dysfunction, reactive oxygen species, protease activation, inflammation, microglial and astrocytic activation, apoptosis/necrosis, and axonal injury expand the lesion.
  6. Clinical hemiplegia: injury to unilateral motor cortex, subcortical white matter, basal ganglia, or corticospinal pathways causes contralateral weakness.
  7. Chronic remodeling: neuronal loss, gliosis, hemispheric atrophy, and abnormal network reorganization create an epileptogenic substrate, producing delayed focal epilepsy.

The relative contributions of seizure-mediated excitotoxicity, inflammation, perfusion failure, venous congestion, and pre-existing vulnerability differ between patients. Pathology has shown inflammatory-degenerative changes, but no single protein dysfunction or enzyme deficiency defines HHE. A pathology/MRI report with mechanistic implications was published by Auvin et al. in June 2007 (DOI); inflammatory-degenerative histology was also reported by Serino et al. in May 2014 (DOI).

Ontology suggestions

  • GO biological process: glutamatergic synaptic transmission (GO:0035249), regulation of membrane potential (GO:0042391), response to hypoxia (GO:0001666), inflammatory response (GO:0006954), microglial activation (GO:0001774), reactive oxygen species metabolic process (GO:0072593), neuron apoptotic process (GO:0051402), gliosis (GO:0042063).
  • Cell Ontology: glutamatergic neuron (CL:0000679), GABAergic neuron (CL:0000617), astrocyte (CL:0000127), microglial cell (CL:0000129), oligodendrocyte (CL:0000128), brain vascular endothelial cell, pericyte.
  • GO cellular components: synapse (GO:0045202), postsynaptic membrane (GO:0045211), mitochondrion (GO:0005739), axon (GO:0030424), myelin sheath (GO:0043209), blood–brain barrier-associated junctions.

Molecular profiling and advanced technologies

No disease-specific validated transcriptomic, proteomic, metabolomic, lipidomic, single-cell, spatial-transcriptomic, CRISPR-screen, or integrated multi-omics dataset was identified. Cytokines, diffusion metrics, and injury proteins remain investigational rather than diagnostic biomarkers.

7. Anatomical structures affected

The central nervous system, particularly one cerebral hemisphere, is primary. Acute abnormalities can involve cortex, subcortical white matter, hippocampus, basal ganglia, thalamus, and corticospinal projections. Chronic findings include unilateral cortical and white-matter volume loss, ventricular enlargement ex vacuo, gliosis, and possible Wallerian degeneration.

Suggested anatomy terms include cerebral hemisphere (UBERON:0001869), cerebral cortex (UBERON:0000956), cerebral white matter (UBERON:0002437), hippocampal formation (UBERON:0002421), basal ganglion (UBERON:0002420), thalamus (UBERON:0001897), and corticospinal tract. Laterality is essential: seizures and hemispheric MRI injury are generally ipsilateral, while hemiplegia is contralateral.

Secondary musculoskeletal consequences include unilateral spasticity, reduced limb growth/use, contracture, hip displacement, scoliosis, and impaired gait; these are complications of upper-motor-neuron injury rather than primary multiorgan disease.

8. Temporal development

  • Onset: acute, usually in infancy or early childhood.
  • Acute phase: prolonged hemiclonic status, often febrile; altered consciousness may persist after motor convulsions stop.
  • Early postictal phase: hemiplegia becomes evident. MRI may initially be normal, but typically develops unilateral swelling, T2/FLAIR hyperintensity, and diffusion restriction.
  • Evolution over weeks to months: edema resolves and unilateral atrophy/gliosis emerges. Longitudinal MRI findings in ten children were reported by Barcia et al. (published December 2013; DOI).
  • Chronic phase: fixed or partially improving hemiparesis; delayed focal seizures may arise after months or years and persist lifelong.

The critical intervention window is the initial status episode: seizure termination and prevention of systemic secondary insults must occur within minutes, not after imaging changes become established.

9. Inheritance and population

No reliable prevalence per 100,000 or annual incidence estimate is available. Published evidence includes individual cases, a 10-child longitudinal MRI cohort, a 35-case clinical/imaging/EEG series, and regional retrospective series. These cannot establish population frequency and are vulnerable to referral and survivor bias.

HHE is not normally inherited. Consequently, Mendelian penetrance, anticipation, carrier frequency, founder effects, consanguinity, and germline mosaicism are not applicable unless an underlying genetic disorder is identified. No reproducible sex ratio, ancestry enrichment, or endemic geographic distribution is established. Apparent regional clusters may reflect infection burden, treatment access, or ascertainment rather than population genetics.

10. Diagnostics

Clinical approach

Diagnosis is clinicoradiologic and longitudinal. The essential history is prolonged unilateral convulsive status followed by persistent contralateral motor deficit. Delayed recurrent focal seizures complete the HHE sequence.

Acute investigations should include:

  • continuous or repeated EEG, particularly when consciousness does not recover, to exclude ongoing nonconvulsive status;
  • urgent MRI brain with DWI/ADC, T2/FLAIR, susceptibility imaging, and vascular sequences; CT is useful when MRI is unavailable but is less sensitive;
  • glucose, electrolytes, calcium, magnesium, blood count, liver/renal tests, inflammatory markers, cultures, and toxicology as indicated;
  • lumbar puncture with microbiology/virology and autoimmune studies when safe and clinically indicated;
  • metabolic testing—lactate, ammonia, plasma amino acids, acylcarnitines, urine organic acids—when presentation, imaging, or family history suggests a metabolic disorder.

The characteristic radiologic evolution is acute unilateral hemispheric edema/restricted diffusion followed by cerebral hemiatrophy. Freeman et al. described “characteristic early magnetic resonance imaging findings” (published January 2002; DOI). A normal very-early MRI does not exclude HHE.

Genetic testing

Genetic testing is not required to confirm acquired HHE, but is appropriate when there was prior developmental abnormality, recurrent fever-sensitive seizures, family history, dysmorphism, congenital anomalies, metabolic clues, or atypical/bilateral imaging.

A practical sequence is an epilepsy/developmental-encephalopathy panel including SCN1A, or trio exome/genome sequencing where phenotype is nonspecific. Chromosomal microarray is reasonable for congenital anomalies or intellectual disability. Mitochondrial, repeat-expansion, karyotype, and FISH testing are not routine unless specifically indicated. No HHE-specific liquid biopsy or omics diagnostic is available.

Differential diagnosis

  • Dravet syndrome: recurrent fever-sensitive hemiclonic/generalized seizures, often SCN1A-related; early MRI is usually normal and fixed unilateral destructive injury is not required.
  • Rasmussen encephalitis: progressive focal seizures, epilepsia partialis continua, and gradually progressive unilateral atrophy rather than a single catastrophic febrile hemiclonic episode.
  • Arterial ischemic stroke/cerebral venous thrombosis: vascular-territory or venous imaging abnormality; seizure may be a consequence rather than the primary insult.
  • Encephalitis/encephalopathy, FIRES/NORSE, or AESD: generally more diffuse or multifocal seizure burden/imaging, although overlap exists.
  • Alternating hemiplegia of childhood: recurrent reversible hemiplegic attacks, often ATP1A3-related, rather than fixed post-status deficit with hemiatrophy.
  • MELAS and metabolic stroke-like disorders: recurrent nonvascular-territory lesions, lactic acidosis, multisystem features.
  • Todd paresis: transient and resolves, without progressive hemispheric atrophy.
  • Structural focal epilepsy: pre-existing malformation or lesion should be distinguishable on baseline/serial imaging.

There is no asymptomatic population, newborn, carrier, or cascade screening program for HHE.

11. Outcome and prognosis

No validated 5- or 10-year survival rate or disease-specific life-expectancy estimate exists. Death can occur during catastrophic status, cerebral edema, or systemic complications, but most literature emphasizes chronic morbidity.

Important long-term outcomes are persistent hemiparesis/spasticity, developmental and intellectual disability, language impairment, visual-field loss, orthopedic complications, and chronic—sometimes drug-resistant—focal epilepsy. Motor recovery is variable; complete recovery is less likely when early weakness is profound and MRI shows extensive cortex, deep nuclei, and white-matter injury.

Plausible adverse prognostic factors include longer/refractory status, delayed seizure control, extensive diffusion restriction, deep-gray involvement, severe edema or raised intracranial pressure, contralateral abnormalities, underlying encephalopathy, and subsequent high seizure burden. None is a clinically validated HHE prognostic biomarker.

12. Treatment

Acute treatment

Treatment follows pediatric convulsive status-epilepticus protocols:

  1. Airway, breathing, circulation; check glucose; correct hypoxia, hypotension, electrolyte disturbances, and hyperthermia.
  2. Prompt benzodiazepine.
  3. Rapid second-line antiseizure medication—commonly levetiracetam, fosphenytoin/phenytoin, or valproate, selected according to age, comorbidity, and suspected syndrome.
  4. Refractory status: pediatric neurocritical care, continuous EEG, anesthetic infusion and/or additional agents according to protocol.
  5. Treat suspected CNS infection empirically until excluded; manage intracranial pressure and severe edema with neurocritical-care/neurosurgical input.

Suggested intervention ontologies are NCIT concepts for Anticonvulsant Therapy, Benzodiazepine, Levetiracetam, Fosphenytoin, Valproic Acid, Mechanical Ventilation, and Intensive Care; exact NCIT codes should be verified in the target terminology release. Relevant chemical annotation examples include diazepam (CHEBI:49575), lorazepam (CHEBI:6539), and valproic acid (CHEBI:39867).

No agent has been proven to prevent hemispheric atrophy after the initial seizure. Therapeutic hypothermia, corticosteroids, IVIG, cytokine blockade, and other neuroprotective approaches are not established HHE therapies.

Chronic treatment and rehabilitation

Antiseizure medication is individualized to seizure type and underlying etiology. Physical, occupational, speech/language, neuropsychological, visual, and orthopedic care should start early. Spasticity may require stretching, orthoses, botulinum toxin, oral antispastic medication, casting, or orthopedic surgery.

For disabling drug-resistant epilepsy arising from a severely injured hemisphere, multidisciplinary presurgical evaluation may support functional hemispherectomy or hemispherotomy. Kim et al. reported surgical treatment of delayed epilepsy in HHE (published May 2008; DOI). Evidence is observational; surgery trades existing or anticipated hemispheric disconnection deficits against seizure control.

A small report described ACTH for intractable HHE epilepsy (Shimakawa et al., August 2015), but this does not establish routine efficacy.

Trials and precision therapy

No dedicated HHE interventional trial or approved gene, cell, RNA, or targeted therapy was retrieved. Open Targets lists no associated therapeutic target for the mapped disease. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome) Genotype-guided treatment applies only when testing identifies another disorder, such as an SCN1A-related epilepsy.

13. Prevention

Primary prevention: no method prevents idiopathic HHE with certainty. Routine immunization and prompt treatment of serious infection reduce some febrile/infectious triggers but have not been shown specifically to prevent HHE.

Secondary prevention: caregiver education and an individualized rescue plan for children with previous prolonged seizures or a fever-sensitive epilepsy may shorten seizure duration. Rapid emergency response, early benzodiazepine administration where prescribed, and escalation according to status protocols are the most rational measures.

Tertiary prevention: control recurrent seizures; provide early rehabilitation; monitor contractures, hip alignment, scoliosis, nutrition, bone health, learning, behavior, communication, and caregiver burden; evaluate drug-resistant epilepsy early for surgery.

Genetic counseling should explain that classic acquired HHE does not itself confer Mendelian recurrence risk. Recurrence counseling must instead be based on any identified underlying disorder.

14. Other species and natural disease

No well-established naturally occurring veterinary equivalent of human HHE was identified in OMIA-oriented or literature searches. Animals can develop prolonged focal seizures, unilateral brain injury, paresis, and later epilepsy, but these observations do not constitute a validated naturally occurring HHE syndrome. There is no known zoonotic transmission.

Orthologues of susceptibility genes such as SCN1A are conserved in mouse, rat, zebrafish, and other vertebrates, but those orthologues model fever-sensitive epilepsy or sodium-channel disease—not the complete acquired HHE sequence.

15. Model organisms

No single model reproduces the full human triad with high fidelity. Relevant induced systems include:

  • Rodent prolonged-status models using kainate, pilocarpine, electrical stimulation, or hyperthermia to study excitotoxicity, edema, neuronal death, gliosis, and epileptogenesis.
  • Immature-animal febrile-seizure/status models, which address developmental susceptibility and the interaction between temperature and seizure injury.
  • SCN1A-deficient mouse or zebrafish models, useful when studying Dravet-related phenocopies, but not representative of most acquired HHE.
  • Organotypic brain slices, neurons, astrocyte/microglia cultures, and blood–brain-barrier systems, which isolate excitotoxic, inflammatory, and vascular mechanisms but cannot model hemiplegia or hemispheric network reorganization.

Major limitations are that chemically induced seizures are often bilateral, lesion laterality is artificial, rodent motor lateralization differs from humans, and models rarely reproduce the age-dependent sequence of fever-triggered unilateral status, permanent contralateral hemiplegia, progressive hemiatrophy, and delayed spontaneous focal epilepsy.

Recent developments and expert assessment

The most directly relevant 2024 publication located was a radiologic case report and literature review by Essetti et al., published online in December 2024 (DOI). Another 2024 report described cerebral hemiatrophy and hemiparesis after hemiclonic status in Dravet syndrome (DOI), reinforcing the distinction between classic acquired HHE and genetically defined fever-sensitive epilepsy.

The main expert conclusion remains that HHE is best understood as a rare acquired clinicoradiologic consequence of prolonged unilateral status in a vulnerable developing brain. Current priorities are rapid status termination, serial MRI/EEG, rigorous investigation for an underlying etiology, early rehabilitation, and surgical evaluation of appropriately selected drug-resistant cases. The major research gaps are prospective incidence data, standardized diagnostic criteria, quantitative prognostic imaging, acute neuroprotection trials, and disease-specific longitudinal multi-omics.

Evidence limitations

Direct abstract quotations could not be supplied reliably for most primary studies because many HHE articles were not available as searchable full text through the retrieval system. Titles quoted above—such as “Low incidence of SCN1A genetic mutation…”—are article titles, not presented as abstract quotations. PMID values were omitted where they could not be verified; DOI links and publication months/years are supplied instead to avoid introducing incorrect identifiers. Numerical estimates should not be inferred from selected imaging or surgical cohorts, and absence of a target or trial in the queried resources is evidence of a current database gap, not proof that no experimental work exists.

References

  1. (OpenTargets Search: hemiconvulsion-hemiplegia-epilepsy syndrome): Open Targets Query (hemiconvulsion-hemiplegia-epilepsy syndrome, 0 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

Artifacts